XML 58 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisitions - Other Information (Details)
$ in Thousands
3 Months Ended 9 Months Ended 189 Months Ended
Jun. 20, 2023
USD ($)
Dec. 28, 2022
USD ($)
Jan. 03, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2023
USD ($)
business
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
business
Dec. 31, 2022
USD ($)
Business Acquisition [Line Items]                
Number of businesses acquired | business             18  
Goodwill arising in the acquisition       $ 673,159 $ 673,159   $ 673,159 $ 717,743
Change in fair value of contingent considerations         $ 11,316 $ 0    
Software or Technology Related Acquisitions                
Business Acquisition [Line Items]                
Number of businesses acquired | business         13      
Integrated Nonclinical Development Solutions, Inc.                
Business Acquisition [Line Items]                
Business combination, consideration transferred     $ 8,048          
Vyasa Analytics, LLC                
Business Acquisition [Line Items]                
Business combination, consideration transferred   $ 29,276            
Goodwill arising in the acquisition   $ 16,589            
Contingent consideration earn out period   3 years            
Contingent consideration percentage of consideration paid in cash   70.00%            
Contingent consideration percentage of consideration paid in stock   30.00%            
Contingent consideration, liability   $ 19,813   31,512 $ 31,512   31,512 $ 31,919
Contingent consideration arrangements, range of outcomes, high       60,000 60,000   60,000  
Vyasa Analytics, LLC | General and administrative                
Business Acquisition [Line Items]                
Change in fair value of contingent considerations         11,699      
Vyasa Analytics, LLC | Minimum                
Business Acquisition [Line Items]                
Contingent consideration payout amount based on revenue achievement   0            
Vyasa Analytics, LLC | Maximum                
Business Acquisition [Line Items]                
Contingent consideration payout amount based on revenue achievement   60,000            
Drug Interaction Solutions University of Washington (DIDB)                
Business Acquisition [Line Items]                
Business combination, consideration transferred $ 8,340              
Goodwill arising in the acquisition $ 2,316              
Contingent consideration earn out period 2 years              
Contingent consideration, liability $ 790     407 407   407  
Change in fair value of contingent considerations       (383)        
Contingent consideration arrangements, range of outcomes, high       $ 2,000 $ 2,000   $ 2,000  
Drug Interaction Solutions University of Washington (DIDB) | Maximum                
Business Acquisition [Line Items]                
Contingent consideration arrangements, range of outcomes, high 2,000              
Customer Relationships | Integrated Nonclinical Development Solutions, Inc.                
Business Acquisition [Line Items]                
Finite-lived intangible assets acquired     2,380          
Customer Relationships | Vyasa Analytics, LLC                
Business Acquisition [Line Items]                
Finite-lived intangible assets acquired   11,400            
Customer Relationships | Drug Interaction Solutions University of Washington (DIDB)                
Business Acquisition [Line Items]                
Finite-lived intangible assets acquired 360              
Developed Technology Rights | Integrated Nonclinical Development Solutions, Inc.                
Business Acquisition [Line Items]                
Finite-lived intangible assets acquired     1,040          
Developed Technology Rights | Vyasa Analytics, LLC                
Business Acquisition [Line Items]                
Finite-lived intangible assets acquired   1,500            
Developed Technology Rights | Drug Interaction Solutions University of Washington (DIDB)                
Business Acquisition [Line Items]                
Finite-lived intangible assets acquired 5,600              
Noncompete Agreements | Integrated Nonclinical Development Solutions, Inc.                
Business Acquisition [Line Items]                
Finite-lived intangible assets acquired     100          
Noncompete Agreements | Vyasa Analytics, LLC                
Business Acquisition [Line Items]                
Finite-lived intangible assets acquired   120            
Trademarks | Integrated Nonclinical Development Solutions, Inc.                
Business Acquisition [Line Items]                
Finite-lived intangible assets acquired     $ 2,910          
Trademarks | Vyasa Analytics, LLC                
Business Acquisition [Line Items]                
Finite-lived intangible assets acquired   $ 80            
Trademarks | Drug Interaction Solutions University of Washington (DIDB)                
Business Acquisition [Line Items]                
Finite-lived intangible assets acquired $ 330